Detalhe da pesquisa
1.
PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
Invest New Drugs
; 36(5): 763-772, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29504069
2.
Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
Invest New Drugs
; 36(6): 961-969, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508248
3.
Caregivers' experiences of caring for non-COVID-19 patients during the pandemic: A qualitative systematic review.
Patient Educ Couns
; 115: 107872, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37413807